Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-24 @ 11:42 PM
NCT ID:
NCT04437251
Eligibility Criteria:
Inclusion Criteria:
* Healthy adults have no ongoing neurological, musculoskeletal issues.
* Individuals with chronic stroke had medical history of a unilateral stroke occurring ≥ 6 months prior to enrollment. MRI or CT evidence from the imaging report shown that the stroke involves the corticospinal tract.
* Individuals with chronic stroke have hemiparesis involving the lower extremity.
* Individuals with chronic stroke have no passive range of motion limitation in bilateral hips and knees. Limitation of ankle passive range of motion to 10 degrees of dorsiflexion or ess.
* Visual acuity can be corrected by glasses or contact lens to 20/20.
* Able to walk independently with/without assistant devices for 10 meters.
* Able to maintain standing position without any assistance for more than 30 sec.
* Evaluation of cognitive status: Mini-mental status examination (MMSE) score ≥ 24.
Exclusion Criteria:
* Pregnant women.
* MRI or CT evidence of involvement of the basal ganglia or cerebellum, evidence of multiple lesions, or evidence of any other brain damage or malignant neoplasm or tumors.
* Have any metal implants, cardiac pacemakers, or history of seizures.
* Ongoing orthopedic or other neuromuscular disorders that will restrict exercise training.
* Any vestibular dysfunction or unstable angina.
* Significant cognitive deficits (inability to follow a 2-step command) or severe receptive or global aphasia\*
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
90 Years
Study:
NCT04437251
Study Brief:
Protocol Section:
NCT04437251